PROVIDER PROFILE · NPI 1659589638

Rashmi UnwalaM.D.

PRACTICEMAYO CLINIC ARIZONASee all providers at this practice →

DermatologyScottsdale, AZI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

486

Unique beneficiaries

—

Total services

624

Distinct HCPCS

Medicare payment

$24K

Peer benchmark

Total Medicare services vs. 277 Dermatology providers in AZ — bottom quintile (cohort median 4,361).

PRESCRIBING · PART D · 2024

Total Rx claims

1,000

Beneficiaries

—

Total drug cost

$1.3M

Distinct drugs

Brand share

24.0%

Top prescribed drugs

Ketoconazole102 claims

Triamcinolone Acetonide101 claims

Secukinumab84 claims

Clobetasol Propionate70 claims

Clindamycin Phosphate43 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$44

Payment records

By payment type

Food and Beverage$44

REFERRAL NETWORK

Where Rashmi Unwala's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 8 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
MAYO CLINIC ARIZONA	108	188
Steven Nelson Dermatology · Scottsdale, AZ	68	99
David Swanson Dermatology · Scottsdale, AZ	18	54
CHIVERS, F	16	30
KRANSDORF, MARK	14	25
Ryan Robetorye Pathology · Scottsdale, AZ	13	18
Mayo Collaborative Services, Inc Clinical Laboratory · Rochester, MN	13	32
Hasan Khamash Nephrology · Phoenix, AZ	11	14

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history